Incyte Corporation

The available data supports a narrow but clear conclusion: reported revenue has grown in every year from 2018 through 2025, rising from $1.88 billion to $5.14 billion, a compound rate of roughly 15% a year across seven compounding periods. Operating income has been far less steady. It was $402.01 million in 2019, a loss of $263.68 million in 2020, $585.78 million in 2021, $579.44 million in 2022, $620.52 million in 2023, $61.37 million in 2024, and $1.51 billion in 2025. The 2024 result is the outlier a casual reader could overlook: revenue still climbed to $4.24 billion, yet operating income nearly collapsed. That gap is the kind of item a reader would want explained in the MD&A, which is not included in this dataset. The file also contains no forensic scores. No Beneish M-Score, Piotroski F-Score, Altman Z-Score or Fog Index is on file, so this synthesis does not assess manipulation-screen results, financial distress zones, or filing readability, and it assigns no value to any of them. Readers who want those screens should check whether the source filings provide them and how each score is defined in standard references. Likewise, no news headlines or risk-factor language is included, so this narrative cannot confirm any product, legal, regulatory or debt matter. What the numbers do show is a company whose top line has expanded steadily while its operating profitability has moved sharply from year to year. Readers may want to look at the full 10-K, particularly the MD&A and risk-factor sections, to see what management attributes the 2024 margin compression and the 2025 recovery to.

Catalyst.The data provided covers only annual revenue and operating income, so the drivers behind these changes cannot be confirmed, because MD&A text is not on file. The numbers show revenue rising from $4.24 billion in 2024 to $5.14 billion in 2025, an increase of $0.90 billion or about 21%. Operating income rose from $61.37 million in 2024 to $1.51 billion in 2025. Revenue has increased in every year of the 2018 to 2025 series, starting from $1.88 billion. Readers may want to look at the MD&A section of the 10-K for management's explanation of what drove the 2025 growth.

Hidden risk.The most visible tension in this data is how thin the margin was in 2024. Operating income was $61.37 million on $4.24 billion of revenue, about 1.4% of sales, compared with about 16.8% in 2023 and about 29.4% in 2025. In 2020 the company reported an operating loss of $263.68 million. A business whose operating profit swings this widely from year to year depends heavily on the timing of its expenses. Because no risk-factor text is on file, this synthesis cannot identify which specific risks management disclosed, so readers may want to check the risk factors section directly.